Citizens Financial Group »

Abcellera Biologics shares owned by Citizens Financial Group

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Citizens Financial Group from 13F filings

Historical chart of Citizens Financial Group investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Citizens Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Citizens Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $811k 312k 2.60
2024-06-30 $923k 312k 2.96

More positions owned by Citizens Financial Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Procter & Gamble Company (PG)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Us Grw Etf (IUSG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)

View all positions for Citizens Financial Group

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
BlackRock
Renaissance Technologies
Tang Capital Management
Federated Investors
Two Sigma Investments
Guardian Capital Advisors
Two Sigma Advisers
Citadel Advisors
Novo A/S

View all funds holding Abcellera Biologics